Integrated Diagnostics Holdings PLC (IDHC) — Capital Reinvestment Ratio

Latest as of June 2025: 0.29x

Integrated Diagnostics Holdings PLC (IDHC) has a Capital Reinvestment Ratio of 0.29x as of June 2025, meaning it reinvests 0% of its operating cash flow ($197.02 Million) in capital expenditures ($56.40 Million). See IDHC FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.29x
Capex / Operating Cash Flow

Operating Cash Flow

$197.02 Million
USD

Capital Expenditures

$56.40 Million
USD

Data as of

Jun 2025
Most recent filing

Integrated Diagnostics Holdings PLC Capital Reinvestment Ratio (2012–2024)

This chart tracks Integrated Diagnostics Holdings PLC's Capital Reinvestment Ratio across 13 annual periods.

Annual Capital Reinvestment Ratio for Integrated Diagnostics Holdings PLC (2012–2024)

Year-by-year Capital Reinvestment Ratio for Integrated Diagnostics Holdings PLC from 2012 to 2024. For live market cap and broader valuation context, see market value of Integrated Diagnostics Holdings PLC.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2024 0.14x $1.57 Billion $224.60 Million ▼ -76.1%
2023 0.60x $543.66 Million $325.93 Million ▼ -59.5%
2022 1.48x $208.73 Million $308.84 Million ▲ +1173.4%
2021 0.12x $2.27 Billion $263.74 Million ▼ -18.6%
2020 0.14x $882.51 Million $126.01 Million ▼ -54.3%
2019 0.31x $697.41 Million $218.00 Million ▼ -47.6%
2018 0.60x $556.31 Million $331.55 Million ▲ +52.7%
2017 0.39x $403.07 Million $157.35 Million ▲ +220.6%
2016 0.12x $398.66 Million $48.54 Million ▼ -57.9%
2015 0.29x $189.86 Million $54.90 Million ▲ +14.6%
2014 0.25x $301.59 Million $76.09 Million ▲ +111.5%
2013 0.12x $209.29 Million $24.97 Million ▲ +196.8%
2012 0.04x $639.10 Million $25.69 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow